Skip to content

Use of the ROSA Knee Robot System for patients undergoing a primary total knee replacement - an early evaluation of the ROSA Knee System.

A clinical evaluation of ROSA Knee 1.0 Robotic Total Knee Application used in primary total knee arthroplasty - a pilot study to evaluate the ROSA Knee System applications and performance intra-operatively.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618000990224
Enrollment
64
Registered
2018-06-13
Start date
2018-10-26
Completion date
2019-09-02
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study aims to collection information on the performance of the robot system intra-operatively. Enrolment is eligible candidates undergoing primary Total Knee Arthroplasty using a Persona total knee implant system or Vanguard total knee implant system or NexGen total knee implant system. There will be three research centres. One surgeon at each centre. Ten participants will be recruited at each centre.

Interventions

The ROSA Knee System is a stereotaxic instrumentation system for total knee replacement surgery. The system is used by the surgeon to assist the surgeon in providing software-defined spatial boundaries for orientation and reference information to identifiable anatomical structures for the accurate placement of knee implant components.

Sponsors

Zimmer Biomet Pty Ltd
Lead SponsorCommercial sector/Industry

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient qualifies for a primary total knee arthroplasty based on the investigator’s clinical judgement Independent of study participation, patient is a candidate for commercially available Persona Total Knee or Vanguard Total Knee or NexGen Total Knee arthroplasty

Exclusion criteria

Patient has active, local infection or previous intra-articular infection in the affected joint Insufficient bone stock on femoral or tibial surfaces Neuropathic arthroplasty Osteomalacia or any metabolic disorder which may impair bone formation Severe instability secondary to the absence of collateral ligament integrity Rheumatoid arthritis accompanied by an ulcer of the skin or history of recurrent breakdown of the skin

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026